Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-3264PMID 27496707PMCID PMC5026619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer

  2015cited by this paper
• Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.

  2015cited by this paper
• Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

  2014cited by this paper
• The Role of Suppressors of Cytokine Signalling in Human Neoplasms

  2014cited by this paper
• Stromal reengineering to treat pancreas cancer.

  2014cited by this paper
• Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.

  2014cited by this paper
• Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

  2014cited by this paper
• Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

  2013cited by this paper
• Contribution of bone marrow derived cells to the pancreatic tumor microenvironment

  2013cited by this paper
• DNA Methyltransferases: A Novel Target for Prevention and Therapy

  2013cited by this paper
• miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells

  2013influential reference
• Deciphering the role of stroma in pancreatic cancer

  2013cited by this paper
• A starring role for stellate cells in the pancreatic cancer microenvironment.

  2013cited by this paper
• Recent progress in pancreatic cancer

  2013cited by this paper
• Hepatocellular carcinoma‐associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4‐miR155‐SOCS1‐MMP9 axis

  2013influential reference
• The Pancreas Cancer Microenvironment

  2012cited by this paper
• Breast Cancer Cells Induce Stromal Fibroblasts to Secrete ADAMTS1 for Cancer Invasion through an Epigenetic Change

  2012cited by this paper
• Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2′-Deoxycytidine

  2012influential reference
• MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer.

  2012cited by this paper
• Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer

  2011cited by this paper
• DNA methylation: superior or subordinate in the epigenetic hierarchy?

  2011cited by this paper
• SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence

  2010cited by this paper
• The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.

  2010cited by this paper
• MethySYBR, a novel quantitative PCR assay for the dual analysis of DNA methylation and CpG methylation density.

  2009cited by this paper
• CROC: finding chromosomal clusters in eukaryotic genomes

  2009cited by this paper
• Pancreatic cancer associated fibroblasts display normal allelotypes

  2008cited by this paper
• No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas

  2008cited by this paper
• Breast-cancer stromal cells with TP53 mutations and nodal metastases.

  2007cited by this paper
• Tumor stroma and regulation of cancer development.

  2006cited by this paper
• Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas

  2006cited by this paper
• Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation.

  2006cited by this paper
• Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type

  2006cited by this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cited by this paper
• Distinct epigenetic changes in the stromal cells of breast cancers

  2005cited by this paper
• Friends or foes — bipolar effects of the tumour stroma in cancer

  2004cited by this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cited by this paper
• Quantitative detection of methylated SOCS-1, a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection

  2004cited by this paper
• Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.

  2004cited by this paper
• Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

  2003cited by this paper
• Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms

  2003cited by this paper
• Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction

  1999cited by this paper
• Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.

  1998cited by this paper
• Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

  1998cited by this paper

• The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer.

  2025cites this paper
• Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery

  2025cites this paper
• Significance of Epigenetic Alteration in Cancer-Associated Fibroblasts on the Development of Carcinoma

  2025cites this paper
• The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities

  2025cites this paper
• Tumor suppressor genes in the tumor microenvironment

  2025cites this paper
• Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer

  2025cites this paper
• Leveraging Epigenetic Alterations in Pancreatic Ductal Adenocarcinoma for Clinical Applications.

  2025cites this paper
• Cancer-associated fibroblasts in carcinogenesis

  2025cites this paper
• Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment

  2025cites this paper
• Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

  2024cites this paper
• Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets

  2024cites this paper
• Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer.

  2024cites this paper
• Spermidine supplementation in honey bees: Autophagy and epigenetic modifications

  2024cites this paper
• Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy

  2024cites this paper
• CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy

  2024cites this paper
• Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities

  2024cites this paper
• Epigenetics as a determinant of radiation response in cancer.

  2024cites this paper
• Circular RNA circTMEM59 inhibits progression of pancreatic ductal adenocarcinoma by targeting miR-147b/SOCS1: An in vitro study

  2024cites this paper
• Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment

  2023influential citation
• Targeting the epigenome to reinvigorate T cells for cancer immunotherapy

  2023cites this paper
• Methylation across the central dogma in health and diseases: new therapeutic strategies

  2023cites this paper
• Cancer-associated fibroblasts: from basic science to anticancer therapy

  2023cites this paper
• Epigenetic regulation and therapeutic targets in the tumor microenvironment

  2023cites this paper
• Epigenetic regulation of cancer-associated fibroblast heterogeneity.

  2023cites this paper
• HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation

  2023cites this paper
• Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?

  2023cites this paper
• Role of epigenetics in pancreatic ductal adenocarcinoma.

  2023cites this paper
• Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment

  2022cites this paper
• From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades

  2022cites this paper
• The cell-line-derived subcutaneous tumor model in preclinical cancer research

  2022cites this paper
• Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.

  2022cites this paper
• Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival post-radiotherapy in oral squamous cell carcinoma patient.

  2022cites this paper
• Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers.

  2022cites this paper
• The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy

  2022cites this paper
• Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia

  2022cites this paper
• Epigenetics in precision medicine of pancreatic cancer

  2022cites this paper
• Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers

  2021cites this paper
• Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy

  2021cites this paper
• Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway

  2021cites this paper
• Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Fibroblasts as immune regulators in infection, inflammation and cancer

  2021cites this paper
• The Role of Epigenetics in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer

  2021cites this paper
• Regulation of antitumor immunity by inflammation-induced epigenetic alterations

  2021cites this paper
• Eugenol modulates genomic methylation and inactivates breast cancer‐associated fibroblasts through E2F1‐dependent downregulation of DNMT1/DNMT3A

  2021influential citation
• Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors

  2021cites this paper
• Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance

  2021cites this paper
• Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?

  2021cites this paper
• Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism

  2021cites this paper
• Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma

  2021cites this paper
• Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment.

  2021cites this paper
• Regulation of antitumor immunity by inflammation-induced epigenetic alterations

  2021cites this paper
• University of Birmingham Fibroblasts as immune regulators in infection, inflammation and cancer

  2021cites this paper
• The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities

  2020cites this paper
• Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma

  2020cites this paper
• Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer

  2020cites this paper
• DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

  2020cites this paper
• Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression

  2020cites this paper
• Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment

  2020cites this paper
• Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer

  2020cites this paper
• Microenvironment in Disease and Aging

  2020cites this paper
• Fibroblast Reprogramming in Gastrointestinal Cancer

  2020cites this paper
• Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma

  2020cites this paper
• DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.

  2020cites this paper
• Cancer-associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer

  2019cites this paper
• Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

  2019cites this paper
• Epigenetic changes in fibroblasts drive cancer metabolism and differentiation

  2019cites this paper
• Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation.

  2019cites this paper
• Diagnostic and prognostic value of the BEX family in lung adenocarcinoma

  2019cites this paper
• Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment

  2019cites this paper
• Precision medicine in pancreatic cancer: treating every patient as an exception.

  2019cites this paper
• DNA Methylation Biomarkers Predict Objective Responses to PD-1/PD-L1 Inhibition Blockade

  2019cites this paper
• PTEN in the Stroma.

  2019cites this paper
• Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis

  2019cites this paper
• The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells

  2019cites this paper
• CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.

  2019influential citation
• Epigenetic silencing of ALX4 regulates microcystin-LR induced hepatocellular carcinoma through the P53 pathway.

  2019cites this paper
• Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells

  2019cites this paper
• Rôle du récepteur des androgènes dans les communications cellulaires au sein du cancer de la prostate

  2018cites this paper
• Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth

  2018cites this paper
• Tumor-Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer.

  2018cites this paper
• Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts

  2018cites this paper
• Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.

  2018cites this paper
• The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer

  2018cites this paper
• CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer.

  2018cites this paper
• Cancer‐associated fibroblasts: Secretions, interactions, and therapy

  2018cites this paper
• Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers

  2018cites this paper
• Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment

  2018cites this paper
• Long-term exposure to carcinoma-associated fibroblasts makes breast cancer cells addictive to integrin β1

  2018influential citation
• The methylation of nuclear and mitochondrial DNA in ageing phenotypes and longevity.

  2017cites this paper
• The role of stromal cancer-associated fibroblasts in pancreatic cancer

  2017cites this paper
• Chemotherapy and tumor microenvironment of pancreatic cancer

  2017cites this paper
• Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance.

  2017cites this paper
• Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression

  2017cites this paper
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward

  2017cites this paper
• Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.

  2017cites this paper
• STAT3 in cancer: A double edged sword.

  2017cites this paper
• DNA methylation in the tumor microenvironment

  2017cites this paper